Korea Biotechnology Industry Organization
Jeong-Sun Seo M.D., Ph. D. is the President of Korea Biotechnology Industry Organization (Korea BIO), and Founder & Chairman of Macrogen. He is currently serving as a Distinguished Professor in Seoul National University Bundang Hospital (SNUBH) and the Director of Precision Medicine Center at SNUBH.
Dr. Seo received both his M.D., and Ph.D. from Seoul National University and pursued postdoctoral training in Rockefeller University to continue his research in molecular oncology.
Dr. Seo’s research is focused on understanding the relationship between genomic, transcriptomic and epigenomic landscape and predisposition to diseases. He first adopted the sequencing technologies to understand the genome and the function of microorganisms such as Zymomonas mobilis (Nature Biotechnology, 2005). In 2001, the AK1 (Altaic Korean) BAC clone library was created to prepare the foundation for understanding genomic differences in the Northeast Asian population. These BAC clones established the foundations for pursuing the Asian Genome Project.
In 2009, Dr. Seo published Northeast Asian individual genome in Nature. In 2016, he also published the Asian reference genome in Nature using De Novo Assembly and phasing method. The Asian reference genome revealed ethnic differences that are more commonly shared within Asian individuals. Nature’s featured press release reported his paper as “the most contiguous human genome mapped to date.”
Through his academic accomplishment, he founded Macrogen in 1997 and served as its chairman since its inception. Macrogen is one of the first biotechnology companies in South Korea and is the first biotechnology company to be listed in the KOSDAQ. Macrogen provides sequencing services to more than hundred countries and generates annual revenue of hundred million dollars.